Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 05 Jan 2017 Primary endpoints amended. Also, time frame for primary endpoint (fMRI (Functional changes in the brain)) changed from 1 year to 28 days.
- 05 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.